Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Propofol, Propofol-Remifentanil and Propofol-Ketamine Anesthesia During Electroconvulsive Therapy
NCT02819375Phase 4Completed
- Sponsor
- Inonu University
- Start
- Jan 2017
- Primary completion
- Mar 2017
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, randomised, single-blind trial in major depressive disorder (MDD) comparing Group Propofol, Group Propofol/Remifentanil and Group Propofol/Ketamine (3 arms). Primary endpoint: Seizure Activity Duration. Started Jan 2017; status: completed.
02
Drugs
propofolremifentanilketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02819375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02819375.